キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/11/15 | 2,416 | 2,441 | 2,415 | 2,422 | +22 | +0.9% | 34,700 |
2022/11/14 | 2,420 | 2,425 | 2,399 | 2,400 | -44 | -1.8% | 59,800 |
2022/11/11 | 2,476 | 2,480 | 2,420 | 2,444 | +18 | +0.7% | 54,100 |
2022/11/10 | 2,427 | 2,457 | 2,410 | 2,426 | -1 | ±0% | 76,500 |
2022/11/09 | 2,485 | 2,514 | 2,413 | 2,427 | -108 | -4.3% | 114,800 |
2022/11/08 | 2,552 | 2,560 | 2,531 | 2,535 | -4 | -0.2% | 47,100 |
2022/11/07 | 2,558 | 2,558 | 2,525 | 2,539 | -8 | -0.3% | 50,700 |
2022/11/04 | 2,622 | 2,623 | 2,545 | 2,547 | -77 | -2.9% | 77,500 |
2022/11/02 | 2,613 | 2,645 | 2,613 | 2,624 | +3 | +0.1% | 41,800 |
2022/11/01 | 2,650 | 2,662 | 2,621 | 2,621 | -8 | -0.3% | 65,000 |
2022/10/31 | 2,606 | 2,632 | 2,605 | 2,629 | +31 | +1.2% | 64,800 |
2022/10/28 | 2,583 | 2,615 | 2,577 | 2,598 | -30 | -1.1% | 215,500 |
2022/10/27 | 2,624 | 2,628 | 2,584 | 2,628 | +3 | +0.1% | 46,300 |
2022/10/26 | 2,598 | 2,635 | 2,585 | 2,625 | +59 | +2.3% | 58,900 |
2022/10/25 | 2,569 | 2,585 | 2,550 | 2,566 | +19 | +0.7% | 65,000 |
2022/10/24 | 2,587 | 2,587 | 2,543 | 2,547 | -29 | -1.1% | 60,800 |
2022/10/21 | 2,580 | 2,582 | 2,554 | 2,576 | -22 | -0.8% | 62,600 |
2022/10/20 | 2,601 | 2,613 | 2,587 | 2,598 | -27 | -1% | 48,800 |
2022/10/19 | 2,633 | 2,643 | 2,619 | 2,625 | -10 | -0.4% | 40,000 |
2022/10/18 | 2,638 | 2,645 | 2,622 | 2,635 | +30 | +1.2% | 51,500 |
2022/10/17 | 2,638 | 2,638 | 2,601 | 2,605 | -41 | -1.5% | 51,300 |
2022/10/14 | 2,617 | 2,650 | 2,577 | 2,646 | +76 | +3% | 100,900 |
2022/10/13 | 2,598 | 2,605 | 2,560 | 2,570 | -35 | -1.3% | 101,600 |
2022/10/12 | 2,609 | 2,617 | 2,568 | 2,605 | +27 | +1% | 92,700 |
2022/10/11 | 2,560 | 2,594 | 2,560 | 2,578 | -22 | -0.8% | 124,900 |
2022/10/07 | 2,597 | 2,612 | 2,572 | 2,600 | -27 | -1% | 83,200 |
2022/10/06 | 2,632 | 2,661 | 2,627 | 2,627 | -7 | -0.3% | 75,700 |
2022/10/05 | 2,633 | 2,642 | 2,610 | 2,634 | +11 | +0.4% | 58,300 |
2022/10/04 | 2,598 | 2,626 | 2,587 | 2,623 | +68 | +2.7% | 88,200 |
2022/10/03 | 2,561 | 2,561 | 2,518 | 2,555 | -18 | -0.7% | 81,000 |
2022/09/30 | 2,590 | 2,602 | 2,557 | 2,573 | +22 | +0.9% | 101,000 |
2022/09/29 | 2,509 | 2,556 | 2,508 | 2,551 | +43 | +1.7% | 100,300 |
2022/09/28 | 2,524 | 2,524 | 2,477 | 2,508 | -1 | ±0% | 114,500 |
2022/09/27 | 2,470 | 2,534 | 2,469 | 2,509 | +16 | +0.6% | 104,800 |
2022/09/26 | 2,473 | 2,515 | 2,473 | 2,493 | +32 | +1.3% | 119,700 |
2022/09/22 | 2,460 | 2,484 | 2,452 | 2,461 | -22 | -0.9% | 62,900 |
2022/09/21 | 2,480 | 2,496 | 2,471 | 2,483 | -25 | -1% | 55,500 |
2022/09/20 | 2,513 | 2,516 | 2,493 | 2,508 | +11 | +0.4% | 60,000 |
2022/09/16 | 2,482 | 2,507 | 2,479 | 2,497 | -7 | -0.3% | 49,200 |
2022/09/15 | 2,501 | 2,509 | 2,484 | 2,504 | -1 | ±0% | 58,500 |
2022/09/14 | 2,496 | 2,507 | 2,481 | 2,505 | -37 | -1.5% | 65,300 |
2022/09/13 | 2,541 | 2,549 | 2,528 | 2,542 | +1 | ±0% | 39,100 |
2022/09/12 | 2,567 | 2,567 | 2,521 | 2,541 | -32 | -1.2% | 34,900 |
2022/09/09 | 2,576 | 2,594 | 2,563 | 2,573 | +29 | +1.1% | 149,700 |
2022/09/08 | 2,515 | 2,548 | 2,515 | 2,544 | +79 | +3.2% | 130,500 |
2022/09/07 | 2,463 | 2,473 | 2,450 | 2,465 | -21 | -0.8% | 74,300 |
2022/09/06 | 2,469 | 2,502 | 2,460 | 2,486 | +40 | +1.6% | 131,700 |
2022/09/05 | 2,462 | 2,470 | 2,437 | 2,446 | -45 | -1.8% | 132,800 |
2022/09/02 | 2,523 | 2,540 | 2,468 | 2,491 | -31 | -1.2% | 152,100 |
2022/09/01 | 2,479 | 2,529 | 2,474 | 2,522 | +36 | +1.4% | 210,400 |
501~
550
件表示中 / 3589件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 363,000円 | +14.5% | -2.3% | 2.48% | 13.28倍 | 0.71倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
住友ファーマ | 60,300円 | +7.5% | - | 0.00% | - | 2.10倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
科研薬 | 429,000円 | +22.8% | +113.0% | 4.43% | 11.44倍 | 1.05倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
ジーエヌアイ | 295,300円 | +52.1% | +23.3% | 0.00% | 20.97倍 | 4.02倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
東和薬品 | 277,000円 | +15.0% | -7.3% | 2.17% | 9.09倍 | 0.86倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム